1. Home
  2. CTKB vs NBN Comparison

CTKB vs NBN Comparison

Compare CTKB & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • NBN
  • Stock Information
  • Founded
  • CTKB 1990
  • NBN 1872
  • Country
  • CTKB United States
  • NBN United States
  • Employees
  • CTKB N/A
  • NBN N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NBN Major Banks
  • Sector
  • CTKB Health Care
  • NBN Finance
  • Exchange
  • CTKB Nasdaq
  • NBN Nasdaq
  • Market Cap
  • CTKB 708.8M
  • NBN 753.2M
  • IPO Year
  • CTKB 2021
  • NBN N/A
  • Fundamental
  • Price
  • CTKB $6.52
  • NBN $93.33
  • Analyst Decision
  • CTKB Strong Buy
  • NBN Buy
  • Analyst Count
  • CTKB 2
  • NBN 2
  • Target Price
  • CTKB $9.25
  • NBN $91.00
  • AVG Volume (30 Days)
  • CTKB 620.3K
  • NBN 54.8K
  • Earning Date
  • CTKB 11-05-2024
  • NBN 01-28-2025
  • Dividend Yield
  • CTKB N/A
  • NBN 0.04%
  • EPS Growth
  • CTKB N/A
  • NBN 12.22
  • EPS
  • CTKB N/A
  • NBN 7.69
  • Revenue
  • CTKB $201,210,000.00
  • NBN $157,668,000.00
  • Revenue This Year
  • CTKB $8.18
  • NBN N/A
  • Revenue Next Year
  • CTKB $11.15
  • NBN $10.37
  • P/E Ratio
  • CTKB N/A
  • NBN $12.08
  • Revenue Growth
  • CTKB 9.88
  • NBN 16.87
  • 52 Week Low
  • CTKB $4.66
  • NBN $49.07
  • 52 Week High
  • CTKB $9.87
  • NBN $105.44
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 50.58
  • NBN 41.61
  • Support Level
  • CTKB $6.04
  • NBN $90.67
  • Resistance Level
  • CTKB $6.55
  • NBN $99.50
  • Average True Range (ATR)
  • CTKB 0.32
  • NBN 2.70
  • MACD
  • CTKB -0.04
  • NBN -1.07
  • Stochastic Oscillator
  • CTKB 42.35
  • NBN 20.72

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About NBN Northeast Bank

Northeast Bank provides banking and financial services to individual and corporate customers in the US. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived primarily from interest and dividends from the bank.

Share on Social Networks: